Viewing Study NCT03904251


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-01-04 @ 8:25 AM
Study NCT ID: NCT03904251
Status: TERMINATED
Last Update Posted: 2023-11-18
First Post: 2019-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module